These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22994085)

  • 1. [Markers of endothelial activation in rheumatoid arthritis].
    Shilikina NP; Yunonin IE; Vinogradov AA; Butusova SV
    Ter Arkh; 2012; 84(8):29-32. PubMed ID: 22994085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endothelial dysfunction in rheumatic patients].
    Shilkina NP; Butusova SV
    Klin Med (Mosk); 2013; 91(4):58-61. PubMed ID: 23879057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Markers of vascular endothelium activation in gout].
    Lapkina NA; Baranov AA; Barskova VG; Abaĭtova NE; Iakunina IA
    Ter Arkh; 2005; 77(5):62-5. PubMed ID: 15989007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [System of microcirculation, markers of vascular wall damage and systematicity of the process in rheumatic diseases].
    Shilkina NP; Butusova SV; Driazhenkova IV
    Angiol Sosud Khir; 2014; 20(1):27-34. PubMed ID: 24722018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients?
    de Groot L; Jager NA; Westra J; Smit AJ; Kallenberg CG; Posthumus MD; Bijl M
    Rheumatology (Oxford); 2015 Jul; 54(7):1257-61. PubMed ID: 25587178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble adhesion molecules and anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy.
    Salih AM; Nixon NB; Dawes PT; Mattey DL
    J Rheumatol; 1999 Mar; 26(3):551-5. PubMed ID: 10090161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment.
    Foster W; Carruthers D; Lip GY; Blann AD
    J Rheumatol; 2010 Apr; 37(4):711-6. PubMed ID: 20156948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis.
    Syngle A; Vohra K; Garg N; Kaur L; Chand P
    Int J Rheum Dis; 2012 Feb; 15(1):45-55. PubMed ID: 22324946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endothelial damage and circadian blood pressure profile in rheumatoid arthritis].
    Shilkina NP; Yunonin IE; Butusova SV; Mikhailova EV; Vinogradov AA
    Ter Arkh; 2019 May; 91(5):89-95. PubMed ID: 32598682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction.
    Foster W; Shantsila E; Carruthers D; Lip GY; Blann AD
    Rheumatology (Oxford); 2009 Mar; 48(3):285-8. PubMed ID: 19153145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.
    Dessein PH; Joffe BI; Singh S
    Arthritis Res Ther; 2005; 7(3):R634-43. PubMed ID: 15899050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis.
    Klimiuk PA; Fiedorczyk M; Sierakowski S; Chwiecko J
    Scand J Rheumatol; 2007; 36(5):345-50. PubMed ID: 17963163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered levels of soluble adhesion molecules in patients with rheumatoid arthritis complicated by peripheral neuropathy.
    El M; Ashour S; Moustafa H; Ahmed I
    J Rheumatol; 2002 Jan; 29(1):57-61. PubMed ID: 11824972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease.
    de Groot L; Hinkema H; Westra J; Smit AJ; Kallenberg CG; Bijl M; Posthumus MD
    Arthritis Res Ther; 2011; 13(6):R205. PubMed ID: 22168993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
    Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
    J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity.
    da Rocha LF; Duarte ÂL; Dantas AT; Mariz HA; Pitta Ida R; Galdino SL; Pitta MG
    J Rheumatol; 2012 Jul; 39(7):1320-5. PubMed ID: 22589261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cerebral perfusion, arterial hypertension and endothelial dysfunction in rheumatoid arthritis].
    Shilkina NP; Spirin NN; Yunonin IE; Vinogradov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3. Vyp. 2):68-75. PubMed ID: 31184627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.